The Cutting Edge of Medical Technology Content, Community & Collaboration
... HHS has unveiled a new multi-point plan aimed at better preparing the US to combat health emergencies such as the H1N1 flu, including development of nucleic acid-based technologies, new centers for medical research, partnerships with industry, enhancing manufacturing capabilities, and other approaches..
... The plan stemmed from a review of US medical countermeasure (MCM) capabilities that HHS Secretary Kathleen Sebelius called for in late 2009 – as a response to the H1N1 flu pandemic – that led to a new report loaded with recommendations for several US agencies...
... The review found that the US needs to: upgrade science and regulatory capacity at the Food and Drug Administration; develop manufacturing processes that can be used to produce more than one type of countermeasure; and that “some of the most promising research and development on countermeasures is done by small, emerging biotech companies with little experience in large-scale manufacturing,” ...
... HHS also said that the government must be better at nurturing new discoveries in their early phases, and so it will create new teams at the National Institutes of Health to identify promising research and to help move it forward..
Tags:
© 2024 Created by CC-Conrad Clyburn-MedForeSight. Powered by